Basic Information
| LncRNA/CircRNA Name | SNHG7 |
| Synonyms | SNHG7, NCRNA00061 |
| Region | GRCh38_9:136721366-136728184 |
| Ensemble | ENSG00000233016 |
| Refseq | NR_003672 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | osteosarcoma |
| ICD-0-3 | NA |
| Methods | qRT-PCR, Luciferase reporter assay, Western blot analysis |
| Sample | The OS cell lines (MG63, SaOS2, HOS, and 143B) and human osteoblastic cell line (hFOB1.19), The OS tissues and corresponding relative normal tissues |
| Expression Pattern | up-regulated |
| Function Description | the LncRNA SNHG7 is upregulated during the development of OS via inhibition of tumor suppressor miR-34s signals. |
| Pubmed ID | 29989838 |
| Year | 2018 |
| Title | Long Noncoding RNA SNHG7 Promotes the Tumor Growth and Epithelial-to-Mesenchymal Transition via Regulation of miR-34a Signals in Osteosarcoma. |
External Links
| Links for SNHG7 | GenBank HGNC NONCODE |
| Links for osteosarcoma | OMIM COSMIC |